These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20543584)

  • 1. An N-, C-terminally truncated basic fibroblast growth factor and LPD (liposome-polycation-DNA) complexes elicits a protective immune response against murine colon carcinoma.
    Zhang XP; Yang L; Shi HS; Zhao X; Deng HX; Xiao WJ; Mao YQ; Kan B; Liu YL; Zhang S; Li ZM; Zhang J; Wei YQ
    Cancer Biol Ther; 2010 Aug; 10(3):276-81. PubMed ID: 20543584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the protective effects of truncated bFGF and native bFGF against murine lung carcinoma.
    Luo Z; Peng X; Shi H; Gong C; Qian Z; Yang L
    Int J Mol Med; 2011 Jul; 28(1):3-8. PubMed ID: 21503566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragalus Saponins and Liposome Constitute an Efficacious Adjuvant Formulation for Cancer Vaccines.
    Zhang XP; Li YD; Luo LL; Liu YQ; Li Y; Guo C; Li ZD; Xie XR; Song HX; Yang LP; Sun SB; An FY
    Cancer Biother Radiopharm; 2018 Feb; 33(1):25-31. PubMed ID: 29466034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vaccine targeting basic fibroblast growth factor elicits a protective immune response against murine melanoma.
    Zhang X; Li NL; Guo C; Li YD; Luo LL; Liu YQ; Duan YY; Li ZD; Xie XR; Song HX; Yang LP; An FY
    Cancer Biol Ther; 2018 Jun; 19(6):518-524. PubMed ID: 29405828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of liposome-polycation-DNA(LPD) and monophosphoryl lipid A(MPL) adjuvant formulations in BALB/c mice models.
    Zhang XP; Cui WH
    Immunol Invest; 2012; 41(4):356-66. PubMed ID: 21864115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel combined conjugate vaccine: enhanced immunogenicity of bFGF with CRM197 as a carrier protein.
    Zhang HL; Yuan C; Zhang DM; Shi HS; Li M; Luo ZC; Wan Y; Lu L; Luo ST; Yang L
    Mol Med Rep; 2011; 4(5):857-63. PubMed ID: 21720718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bFGF peptide combined with the pVAX-8CpG plasmid as adjuvant is a novel anticancer vaccine inducing effective immune responses against Lewis lung carcinoma.
    Li M; Shi HS; Zhang HL; Luo ZC; Wan Y; Lu L; Luo ST; Yang L
    Mol Med Rep; 2012 Mar; 5(3):625-30. PubMed ID: 22200843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble production and function of vascular endothelial growth factor/basic fibroblast growth factor complex peptide.
    Zhang Q; Lao X; Huang J; Zhu Z; Pang L; Tang Y; Song Q; Huang J; Deng J; Deng N; Yang Q; Sengupta AM; Xiong L
    Biotechnol Prog; 2015; 31(1):194-203. PubMed ID: 25271020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of tumor with vaccine based on basic fibroblast growth factor-activated fibroblasts.
    Li X; Wang Y; Zhao Y; Yang H; Tong A; Zhao C; Shi H; Li Y; Wang Z; Wei Y
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):271-80. PubMed ID: 24322179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
    Rice J; Buchan S; Stevenson FK
    J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice.
    He QM; Wei YQ; Tian L; Zhao X; Su JM; Yang L; Lu Y; Kan B; Lou YY; Huang MJ; Xiao F; Liu JY; Hu B; Luo F; Jiang Y; Wen YJ; Deng HX; Li J; Niu T; Yang JL
    J Biol Chem; 2003 Jun; 278(24):21831-6. PubMed ID: 12651849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced therapeutic effects against murine colon carcinoma induced by a Colon 26/Ag85A-CD226 tumor cell vaccine.
    Li Y; Yang F; Sang L; Zhu J; Han X; Shan F; Li S; Zhai J; Wang D; Lu C; Sun X
    Oncol Rep; 2015 Oct; 34(4):1795-804. PubMed ID: 26238268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.
    Adris S; Chuluyan E; Bravo A; Berenstein M; Klein S; Jasnis M; Carbone C; Chernajovsky Y; Podhajcer OL
    Cancer Res; 2000 Dec; 60(23):6696-703. PubMed ID: 11118055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L; Kedl R; Dow S
    Cancer Gene Ther; 2006 Nov; 13(11):1033-44. PubMed ID: 16841080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A DNA vaccine encoding the extracellular domain of porcine endoglin induces antitumor immunity in a mouse colon carcinoma model].
    Jiao JG; Zhang YD; Li YN
    Ai Zheng; 2005 Oct; 24(10):1179-83. PubMed ID: 16219129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel vaccine delivery system: biodegradable nanoparticles in thermosensitive hydrogel.
    Wu QJ; Zhu XC; Xiao X; Wang P; Xiong da K; Gong CY; Wang YS; Yang L; Wei YQ
    Growth Factors; 2011 Dec; 29(6):290-7. PubMed ID: 21981422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary antitumor immunity induced by plasmid DNA encoding secreted and cytoplasmic human ErbB-2.
    Piechocki MP; Pilon SA; Wei WZ
    J Immunol; 2001 Sep; 167(6):3367-74. PubMed ID: 11544327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of high-molecular-mass forms of basic fibroblast growth factor produced by hepatocellular carcinoma cells: possible involvement of basic fibroblast growth factor in hepatocarcinogenesis.
    Shimoyama Y; Gotoh M; Ino Y; Sakamoto M; Kato K; Hirohashi S
    Jpn J Cancer Res; 1991 Nov; 82(11):1263-70. PubMed ID: 1721615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.